论文部分内容阅读
目的:分析比较经鼻间歇正压通气与经鼻持续气道正压通气在新生儿呼吸窘迫综合征治疗中的疗效及应用价值。方法:对我院收治患有呼吸窘迫综合征的68例早产儿,随机分组,分别采用经鼻间歇正压通气(NIPPV)或经鼻持续气道正压通气(NCPAP)进行治疗,对两组患者治疗后的临床疗效加以评价。结果:两组患儿经治疗12 h后,观察组pH和OI值均高于对照组,均有显著性差异(P<0.05)。观察组治疗成功率为76.47%,对照组治疗成功率为47.06%,两组患儿在治疗成功率方面有显著性差异(P<0.05)。结论:经鼻间歇正压通气治疗新生儿呼吸窘迫综合征,安全有效,值得广泛推广应用。
Objective: To compare and analyze the efficacy and value of nasal intermittent positive pressure ventilation and nasal continuous positive airway pressure ventilation in the treatment of neonatal respiratory distress syndrome. Methods: A total of 68 premature infants with respiratory distress syndrome admitted to our hospital were randomly divided into three groups: nasal intermittent positive pressure ventilation (NIPPV) or nasal continuous positive airway pressure (NCPAP) Patients after treatment to evaluate the clinical efficacy. Results: After 12 hours of treatment, the pH and OI of the observation group were higher than those of the control group (P <0.05). The success rate of observation group was 76.47%, the control group, the success rate was 47.06%, two groups of children in the treatment success rate was significantly different (P <0.05). Conclusion: Nasal intermittent positive pressure ventilation is safe and effective in the treatment of neonatal respiratory distress syndrome. It is worth to be widely applied.